Aspartate-β-hydroxylase and hypoxia marker expression in head and neck carcinomas: implications for HPV-associated tumors
Authors:
Open Access
- 10 June 2024
- journal article
- research article
- Published by Springer Nature in Infectious Agents and Cancer
- Vol. 19 (1) , 1-13
Abstract
Background: A proportion of head and neck carcinomas (HNSCCs) are induced by high-risk human papillomaviruses (HPVs) and are associated with better patient outcomes compared to patients with HNSCCs related to tobacco and alcohol abuse. In the microenvironment of solid tumors, including HNSCCs, oxygen levels are often reduced, and a hypoxic state is induced. This can lead to a poor treatment response and a worse patient prognosis. One of the hypoxia-responsive genes is aspartate-β-hydroxylase (ASPH), whose activity promotes the growth, invasiveness, and metastasis of many types of solid tumors. Methods: In our study, HNSCC samples were analyzed for the expression of ASPH and selected endogenous hypoxia markers by real-time PCR and/or multiplex fluorescence immunohistochemistry. Results: Except for the EPAS1 gene, which had higher mRNA expression in the HPV-negative group of HNSCC (p < 0.05), we found no other differences in the expression of the tested genes that were related to HPV status. On the contrary, a statistically significantly higher number of cells producing ASPH (p < 0.0001), HIF1A (p < 0.0001), GLUT1 (p < 0.0001), and MMP13 (p < 0.05) proteins were detected in the HPV-positive tumor group than in the HPV-negative sample group. All the evaluated markers, except for MMP9/13, were more abundant in the tumor parenchyma than in the tumor stroma. The Cox proportional hazard models showed that increased numbers of cells with GLUT1 and HIF1A protein expression were positive prognostic markers for overall and disease-specific survival in patients independent of HPV tumor status. Conclusion: The study examined HNSCC samples and found that elevated ASPH and hypoxia marker proteins, typically associated with poor prognosis, may actually indicate active HPV infection, the strongest prognostic factor in HNSCC patients. In cases where HPV status is uncertain, increased expression of HIF1A and GLUT1 can serve as positive prognostic factors.Keywords
Funding Information
- Ministry of Education, Youth and Sports, Czech Republic (Inter-Excellence programme (No. LTAUSA18003))
- European Union - Next Generation EU (Programme EXCELES, ID Project No. LX22NPO5103)
- Charles University, Prague, Czech Republic (SVV260679)
This publication has 55 references indexed in Scilit:
- Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial.2009
- Hypoxia-specific stabilization of HIF-1alpha by human papillomavirusesVirology, 2009
- Strong Immunohistochemical Expression of Vascular Endothelial Growth Factor Predicts Overall Survival in Head and Neck Squamous Cell CarcinomaAnnals of Surgical Oncology, 2007
- Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinomaJournal of Cancer Research and Clinical Oncology, 2005
- HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floorBMC Cancer, 2005
- Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer.2003
- Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients.2002
- Activation of the HIF pathway in cancerCurrent Opinion in Genetics & Development, 2001
- HIF-1 and mechanisms of hypoxia sensingCurrent Opinion in Cell Biology, 2001
- Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation.2000